Category Specific RSS

Samantha Freidin

Paradigm’s study could give options to those with this rare incurable disease

Clinical stage biopharmaceutical company Paradigm Biopharmaceuticals (ASX: PAR) has been given the green light to go ahead with a Phase…

5 years ago

Move over x-ray: 4D Medical’s respiratory scanning tech could be the new standard in imaging

Invented in 1895 and becoming the standard in the early 1900s, the x-ray has long been the backbone of many…

5 years ago

Spray-on skin revenue exceeds initial forecasts

The inventors of “spray-on skin”, Avita Medical (ASX: AVH) have today released their financial results for the fiscal fourth quarter…

5 years ago

Goop might have been right…

The keto diet is proving to be more than just another “It” diet touted by Goop with interesting research showing…

5 years ago

IPO Watch: Gefen Technologies to list on ASX with digital marketing platform for agents

With initial plans to list in the Australian market last year furloughed by the pandemic, Israeli tech company Gefen Technologies…

5 years ago

How Noxopharm is overhauling the way we approach cancer treatment

Traditional chemotherapy and radiotherapy have long been the standard of care for cancer treatment, but it's no secret that there…

5 years ago